http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SG-188298-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b45180365a29ab24a097c55d7d4192e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
filingDate 2011-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b6b92b551f02694ef67607df4965929
publicationDate 2013-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SG-188298-A1
titleOfInvention Deuterated analogs of pridopidine useful as dopaminergic stabilizers
abstract The present invention provides novel deuterated analogs of Pridopidine, i.e. 4-(3-methanesulfonyl-phenyl)-1 -propyl-piperidine. Pridopidine is a drug substance currently in clinical development for the treatment of Huntington's disease. In other aspects the invention relates to pharmaceutical compositions 10 comprising a deuterated analog of Pridopidine of the invention, and to therapeutic applications of these analogs.
priorityDate 2010-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9795739

Total number of triples: 20.